Effectiveness, tolerability and safety of Direct Acting Antivirals in Mexican individuals with Hepatitis C virus genotype-1 and previous pegylated interferon and ribavirin therapy

Effectiveness, tolerability and safety of Direct Acting Antivirals in Mexican individuals with Hepatitis C virus genotype-1 and previous pegylated interferon and ribavirin therapy

Background Direct Acting Antivirals (DAAs) represent a large improvement in the treatment of chronic hepatitis C, resulting in <90% sustained virological response (SVR). There are no reports on the real-world DAA response for Mexico and few reports exist for Latin America. The aim of the study wa...

Full description

Bibliographic Details
Main Authors: Daniel Melendez-Mena, Miguel Angel Mendoza-Torres, Virginia Sedeño-Monge, Víctor Hugo García y García, Elain Rivera-García, Laura Sánchez-Reza, María del Carmen Baxin Domínguez, Belinda Guzmán-Flores, Ygnacio Martinez-Laguna, José Manuel Coronel Espinoza, Iván Galindo-Santiago, Juan Carlos Flores-Alonso, Verónica Vallejo-Ruiz, Paulina Cortes-Hernandez, Julio Reyes-Leyva, Francisca Sosa-Jurado, Gerardo Santos-López
Format: Article
Language:English
Published: PeerJ Inc. 2021-09-01
Series:PeerJ
Subjects:
Hepatitis C
Sustained viral response
Direct acting antivirals
Child-Pugh-Score
FIB-4
APRI index
Online Access:https://peerj.com/articles/12051.pdf

Internet

https://peerj.com/articles/12051.pdf

Similar Items